The Cooper Companies, Inc. (NASDAQ: COO) is a Healthcare company (Medical - Instruments & Supplies) with a market capitalization of $11.5B. The Maz Rating grades it against the other companies in its sector.
The Cooper Companies, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $60.72, The Cooper Companies, Inc. trades at 20.8x trailing earnings, 2.7x sales and 1.4x book value, with an EV/EBITDA of 15.3. Over the last twelve months it generated about $4.2B of revenue and $556M of net income. It runs a gross margin of 63.6%, an operating margin of 12.9% and a net margin of 13.5%. It shows return on equity of 6.9%, return on invested capital of 4.8% and a free cash flow yield of 5.9%. On the balance sheet: a debt-to-equity ratio of 0.31 and a current ratio of 1.22. Over the past 52 weeks the share price ranged from $51.01 to $89.83, with a beta of 0.82.
The Cooper Companies, Inc. does not currently pay a dividend.
28 Wall Street analyst ratings cover the stock: 14 Buy, 13 Hold and 1 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.